Financials
- Market Capitalization 217.03 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.53
Fiyat/satışlar oranı
8.08
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3451 | KROS Keros Therapeutics, Inc. - common stock | 11.48 USD | -1.12% | -0.17% | +3.42% | -23.97% | 227.62 M USD | ||
| 3469 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.74 USD | -1.44% | +0.37% | +4.58% | -6.16% | 220.77 M USD | ||
| 3479 | STRO Sutro Biopharma, Inc. - Common Stock | 12.87 USD | -3.09% | -12.27% | -24.69% | -25.99% | 213.40 M USD | ||
| 3494 | TRDA Entrada Therapeutics, Inc. - Common Stock | 5.33 USD | -3.09% | -0.93% | -21.62% | -23.53% | 207.53 M USD |